Open access calls for ground rules

However welcome the rush to make information readily available for all, there are several considerations that have to be taken into account.

A window of opportunity opens in the US

For several years, the United States Agency for International Development has been under growing pressure to adopt a more long-term approach to its support of science and technology in developing countries. The agency now supports a wide spectrum of activities, but many feel that all these could benefit from a more coherent commitment.

Science, meet policy. Now shake hands.

Mention the word policy and many scientists instinctively reach for their gun. The reality is that science needs policymakers as much as policymakers need science. The obvious reason is financial. Modern science is generally accepted as a public good -- an activity that benefits all members of society, rather than selective groups -- and, as a result, something that should be supported from the public purse.

Lessons from the tsunami

There have recently been encouraging signs that science and technology are climbing back on to the international development agenda. There could not be a more dramatic -- or terrible -- illustration of the urgent need for this attention than the devastation that swept through many of the coastal communities of south and south-east Asia as a result of the December 26 tsunami.

The heat is turned on Third World air polluters

Some of the most important issues to be addressed in the climate change talks that opened in Buenos Aires is how Brazil, China and India can be persuaded to tackle global warming. Also high on the agenda, is getting the delegates to agree on a comprehensive "road map" for what happens after the Kyoto Protocol commitment period ends.

Many good drugs, no way to get them to the sick

More than six million children die each year in the developing world from diseases that could be prevented by simple interventions. While effective mechanisms for getting the result of biomedical research to the patients who could most benefit from it remains near the top of the priority list, little research is invested in the 'how'.
 1 2 >